rca4
Small moleculeexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2021 (NCT05169554)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05169554 | Phase 2 | Dec 1, 2021 | Fondation Raoul Follereau, Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID), GlaxoSmithKline, Universidad Carlos III Madrid, Université d'Abomey-Calavi, University of Zaragoza |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fondation Raoul Follereau | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID) | Academic/Hospital | 1 | 1 | 1 | 2021 |
| GlaxoSmithKline | For profit | 1 | 0 | 1 | 2021 |
| Universidad Carlos III Madrid | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Université d'Abomey-Calavi | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Zaragoza | Academic/Hospital | 1 | 0 | 1 | 2021 |
6 organizations
Page 1 / 1